Predictions
Sartorius Stedim Biotech S.A.
Start price
Target price
Perf. (%)
€226.00
30.09.23
30.09.23
-
30.09.24
30.09.24
-15.49%
14.10.23
14.10.23
MicroVision Inc
Start price
Target price
Perf. (%)
€2.11
27.09.23
27.09.23
€4.00
27.09.24
27.09.24
5.76%
23.11.23
23.11.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
Sientra Inc.
Start price
Target price
Perf. (%)
€2.52
25.09.23
25.09.23
€5.20
25.09.24
25.09.24
-23.41%
11.10.23
11.10.23
Could be very worthwhile Investment >20% year
Vita 34 AG
Start price
Target price
Perf. (%)
€4.76
19.09.23
19.09.23
€6.00
19.09.24
19.09.24
-1.68%
30.09.23
30.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
MicroVision Inc
Start price
Target price
Perf. (%)
€2.02
19.09.23
19.09.23
€4.00
19.09.24
19.09.24
4.43%
27.09.23
27.09.23
Fair valuation
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Cytosorbents Corp.
Start price
Target price
Perf. (%)
€1.83
17.09.23
17.09.23
-
17.09.24
17.09.24
-52.14%
19.01.24
19.01.24
Probably not worthwhile Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€1.32
08.09.23
08.09.23
-
08.09.24
08.09.24
10.08%
15.09.23
15.09.23
Could be very worthwhile Investment >20% year
Vita 34 AG
Start price
Target price
Perf. (%)
€4.79
07.09.23
07.09.23
-
07.09.24
07.09.24
-4.59%
16.09.23
16.09.23
Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.67
02.09.23
02.09.23
€17.00
02.09.24
02.09.24
-5.50%
16.09.23
16.09.23
Sartorius AG VZO
Start price
Target price
Perf. (%)
€354.20
29.08.23
29.08.23
€450.00
29.08.24
29.08.24
-35.43%
25.10.23
25.10.23
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€29.39
25.08.23
25.08.23
-
25.08.24
25.08.24
0.20%
02.09.23
02.09.23
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€30.17
11.08.23
11.08.23
-
11.08.24
11.08.24
-3.38%
19.08.23
19.08.23
T2 Biosystems Inc.
Start price
Target price
Perf. (%)
€0.28
08.08.23
08.08.23
€1.00
08.02.24
08.02.24
-41.28%
08.02.24
08.02.24
Tabula Rasa HealthCare Inc
Start price
Target price
Perf. (%)
€9.35
08.08.23
08.08.23
-
08.08.24
08.08.24
5.88%
11.12.23
11.12.23
Probably not worthwhile Investment